Clinical Trial Update: Electrical and Formocresol Pulpotomy in Primary Molars [NA]

View source ↗

Summary

The clinical trial evaluating electrical pulpotomy and formocresol pulpotomy in primary molars has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Reversible Pulpitis

Drugs mentioned

• Formocresol (Formocresol)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Reversible Pulpitis, Caries | NA | Status: TERMINATED